Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Rutherrin

<< Previous

Bullboard Posts

Next >>

Comment by Marco321on Apr 16, 2022 2:05pm

190 Views

Post# 34607670

RE:RE:RE:RE:RE:Rutherrin

With a new target price of $1.20 from Research Capital I am not sure that I understand your comments. Things are definitely looking better than ever, even if it doesn't feel that way in this difficult and risk-adverse macro market environment.

All in my opinion.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program